Mouse tumor models have shown that therapeutic treatment can promote this “cold” to “hot” transition by activating antigen-specific CD8+ T cells that travel to and infiltrate the tumor and release pro-inflammatory cytokines in the TME (4, 39). Here, CD8A is linked to neoplasm.